Applied Dna Sciences Inc

NASDAQ:APDN

0.34

+0.01 (+1.63%)

Market Cap (Intraday)	5.92M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.95 Million
Adjusted EPS	-$0.23

See more estimates

10-Day MA	$0.36
50-Day MA	$0.50
200-Day MA	$0.90

See more pivots

Applied Dna Sciences Inc Stock, NASDAQ:APDN

50 Health Sciences Drive, Stony Brook, Stony Brook, New York 11790

United States of America

Phone: +1.631.240.8800

Number of Employees: 55

http://www.adnas.com

Description

Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.